Pediatric High-Grade Glioma: Role of Microsatellite Instability

Author(s):  
Marta Viana-Pereira ◽  
Chris Jones ◽  
Rui Manuel Reis
2013 ◽  
Vol 333 ◽  
pp. e603
Author(s):  
Y. Chornenkyy ◽  
S. Agnihotri ◽  
P. Buczkowicz ◽  
P. Rakopoulos ◽  
O. Becher ◽  
...  

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi213-vi213
Author(s):  
James Ross ◽  
Zhihong Chen ◽  
Frank Szulzewsky ◽  
Matthew Schniederjan ◽  
Oren Becher ◽  
...  

2020 ◽  
Vol 21 (24) ◽  
pp. 9654
Author(s):  
Santiago Haase ◽  
Fernando M. Nuñez ◽  
Jessica C. Gauss ◽  
Sarah Thompson ◽  
Emily Brumley ◽  
...  

In this review, we discuss the molecular characteristics, development, evolution, and therapeutic perspectives for pediatric high-grade glioma (pHGG) arising in cerebral hemispheres. Recently, the understanding of biology of pHGG experienced a revolution with discoveries arising from genomic and epigenomic high-throughput profiling techniques. These findings led to identification of prevalent molecular alterations in pHGG and revealed a strong connection between epigenetic dysregulation and pHGG development. Although we are only beginning to unravel the molecular biology underlying pHGG, there is a desperate need to develop therapies that would improve the outcome of pHGG patients, as current therapies do not elicit significant improvement in median survival for this patient population. We explore the molecular and cell biology and clinical state-of-the-art of pediatric high-grade gliomas (pHGGs) arising in cerebral hemispheres. We discuss the role of driving mutations, with a special consideration of the role of epigenetic-disrupting mutations. We will also discuss the possibilities of targeting unique molecular vulnerabilities of hemispherical pHGG to design innovative tailored therapies.


PLoS ONE ◽  
2011 ◽  
Vol 6 (5) ◽  
pp. e20588 ◽  
Author(s):  
Marta Viana-Pereira ◽  
Alicia Lee ◽  
Sergey Popov ◽  
Dorine A. Bax ◽  
Safa Al-Sarraj ◽  
...  

2019 ◽  
Vol 130 ◽  
pp. e324-e332 ◽  
Author(s):  
Naama Peshes-Yeloz ◽  
Lior Ungar ◽  
Anton Wohl ◽  
Elad Jacoby ◽  
Tamar Fisher ◽  
...  

2015 ◽  
Vol 17 (suppl 3) ◽  
pp. iii12-iii12
Author(s):  
C. Lasthaus ◽  
M. Litzler ◽  
C. Bour ◽  
D. Guenot ◽  
N. Entz-Werle

Author(s):  
Cong He ◽  
Luoyan Sheng ◽  
Deshen Pan ◽  
Shuai Jiang ◽  
Li Ding ◽  
...  

High-grade glioma is one of the most lethal human cancers characterized by extensive tumor heterogeneity. In order to identify cellular and molecular mechanisms that drive tumor heterogeneity of this lethal disease, we performed single-cell RNA sequencing analysis of one high-grade glioma. Accordingly, we analyzed the individual cellular components in the ecosystem of this tumor. We found that tumor-associated macrophages are predominant in the immune microenvironment. Furthermore, we identified five distinct subpopulations of tumor cells, including one cycling, two OPC/NPC-like and two MES-like cell subpopulations. Moreover, we revealed the evolutionary transition from the cycling to OPC/NPC-like and MES-like cells by trajectory analysis. Importantly, we found that SPP1/CD44 interaction plays a critical role in macrophage-mediated activation of MES-like cells by exploring the cell-cell communication among all cellular components in the tumor ecosystem. Finally, we showed that high expression levels of both SPP1 and CD44 correlate with an increased infiltration of macrophages and poor prognosis of glioma patients. Taken together, this study provided a single-cell atlas of one high-grade glioma and revealed a critical role of macrophage-mediated SPP1/CD44 signaling in glioma progression, indicating that the SPP1/CD44 axis is a potential target for glioma treatment.


Sign in / Sign up

Export Citation Format

Share Document